Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRO
8626
PUT
DELISTED
PROS Holdings
PRO
| $485K | ﹤0.01% |
+18,500
| New | +$523K |
|
8627
CALL
Smart Sand
SND
$208M
| $485K | ﹤0.01% |
242,300
+29,700
| +14% | +$103K |
|
8628
PUT
Diodes
DIOD
$4.95B
| $484K | ﹤0.01% |
7,500
-4,900
| -40% | -$357K |
|
8629
CALL
Keros Therapeutics
KROS
$208M
| $484K | ﹤0.01% |
17,500
+10,400
| +146% | +$456K |
|
8630
PUT
Navient
NAVI
$859M
| $484K | ﹤0.01% |
34,600
+4,100
| +13% | +$63.8K |
|
8631
Relay Therapeutics
RLAY
$4.53B
| $484K | ﹤0.01% |
28,919
-71,175
| -71% | -$1.53M |
|
8632
Vanguard Morningstar Mid-Cap ETF
VO
$111B
| $484K | ﹤0.01% |
9,836
-19,772
| -67% | -$1.07M |
|
8633
PUT
Colliers International
CIGI
$5.29B
| $483K | ﹤0.01% |
4,400
-10,500
| -70% | -$1.2M |
|
8634
PUT
CubeSmart
CUBE
$9.26B
| $483K | ﹤0.01% |
11,300
-1,800
| -14% | -$82.8K |
|
8635
Quanex
NX
$953M
| $483K | ﹤0.01% |
21,214
-2,744
| -11% | -$57.3K |
|
8636
Invesco Active US Real Estate Fund
PSR
$59.6M
| $483K | ﹤0.01% |
+5,054
| New | +$525K |
|
8637
CALL
First American
FAF
$7.47B
| $482K | ﹤0.01% |
9,100
-2,600
| -22% | -$151K |
|
8638
Invesco BulletShares 2028 Municipal Bond ETF
BSMS
$316M
| $481K | ﹤0.01% |
20,695
-43,960
| -68% | -$1.03M |
|
|
POWR
8639
iShares U.S. Power Infrastructure ETF
POWR
$468M
| $481K | ﹤0.01% |
+22,674
| New | +$532K |
|
8640
Fidelity Real Estate Investment ETF
FPRO
$16.5M
| $481K | ﹤0.01% |
+21,882
| New | +$524K |
|
8641
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$89.9M
| $480K | ﹤0.01% |
7,449
+4,883
| +190% | +$446K |
|
8642
iShares Currency Hedged MSCI Japan ETF
HEWJ
$767M
| $480K | ﹤0.01% |
12,833
-82,116
| -86% | -$3.11M |
|
8643
CALL
Strategic Education
STRA
$1.79B
| $480K | ﹤0.01% |
6,800
-1,000
| -13% | -$66.3K |
|
8644
PUT
Twist Bioscience
TWST
$7.8B
| $479K | ﹤0.01% |
13,700
-10,000
| -42% | -$354K |
|
8645
PUT
Holley
HLLY
$370M
| $478K | ﹤0.01% |
45,500
+29,800
| +190% | +$325K |
|
|
ITI
8646
DELISTED
Iteris, Inc.
ITI
| $478K | ﹤0.01% |
165,087
+95,013
| +136% | +$264K |
|
|
SOVO
8647
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $478K | ﹤0.01% |
30,100
-139,299
| -82% | -$2.02M |
|
|
ASPY
8648
DELISTED
ASYMmetric Smart S&P 500 ETF
ASPY
| $478K | ﹤0.01% |
17,674
-7,539
| -30% | -$206K |
|
|
FOLD
8649
CALL
DELISTED
Amicus Therapeutics
FOLD
| $477K | ﹤0.01% |
44,400
+14,000
| +46% | +$115K |
|
8650
PUT
Gerdau
GGB
$9.42B
| $477K | ﹤0.01% |
140,238
+2,394
| +2% | +$10.7K |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.